Connect with us
Twitter Files reveals Pfizer board member's attempt to suppress debate on Covid vaccines Twitter Files reveals Pfizer board member's attempt to suppress debate on Covid vaccines

News

Twitter Files reveals Pfizer board member’s attempt to suppress debate on Covid vaccines

Published

on

In another installment of the Twitter Files released on Monday, screenshots of an email conversation between Scott Gottlieb, a board member at Pfizer, with Todd O’Boyle, a senior manager of public policy at Twitter.

Alex Berenson, a former reporter for the New York Times, shared this installment. Berenson noted that Gottlieb “used the same Twitter lobbyist as the White House to suppress debate on Covid vaccines, including from a fellow head of the US FDA.”

https://twitter.com/elonmusk/status/1612544141866729473

Gottlieb shared a tweet by Doctor Brett Giroir that said that the Covid19 natural immunity was superior to vaccine immunity by a lot.

Advertisement

“This is the kind of stuff that’s corrosive. Here he draws a sweeping conclusion off a single retrospective study in Israel that hasn’t been peer-reviewed. But this tweet will end up going viral and driving news coverage,” Gottlieb said.

Credit: Alex Berenson

Berenson noted that he found the email while searching records while at Twitter last week. He found that through Jira, Twitter’s internal system for managing complaints, O’Boyle forwarded Gottlieb’s email to the Twitter Strategic Response team, which was responsible for handling concerns for the platform’s most important employees and users.

“Please see this report from the former FDA commissioner,” O’Boyle wrote. Berenson noted that O’Boyle failed to mention that Gottlieb was a Pfizer board member “with a financial interest in pushing mRNA shots.”

Although a Strategic Response analyst found that the tweet did not violate any of Twitter’s misinformation rules, the tweet ended up being flagged as misleading. Berenson pointed out that the tweet remains flagged despite several studies confirming the accuracy of Girior’s tweet.

 

Advertisement

Credit: Alex Berenson

 

Following that, Gottlieb complained about a tweet from Justin Hart, whose Twitter following was over 100,000. Berenson pointed out that although Gottlieb’s objection to Hart’s tweet, which mentioned a viral pathogen with a child mortality rate of <>0% wasn’t clear. However, he added, Pfizer should soon be approved for children ages 5 to 11. Again, O’Boyle didn’t mention Gottlieb’s connection with Pfizer when forwarding the report.

Twitter didn’t act on Gottlieb’s request this time. Berenson also noted that Gottlieb was “pressing Twitter to act against me.” He added that Gottlieb’s action was part of a larger one that included the Biden White House and Andrew Slavitt. He said the group worked publicly and privately to pressure Twitter until it had no option but to ban him.

“I will have more to say about my own case and will be suing the White House, Slavitt, Gottlieb, and Pfizer shortly,” Berenson wrote.

The Twitter Files is continuing to be released, and you can read our articles on them here.

Advertisement

Your feedback is welcome. If you have any comments or concerns or see a typo, you can email me at johnna@teslarati.com. You can also reach me on Twitter at @JohnnaCrider1.

Teslarati is now on TikTok. Follow us for interactive news & more. Teslarati is now on TikTok. Follow us for interactive news & more. You can also follow Teslarati on LinkedInTwitter, Instagram, and Facebook.

Johnna Crider is a Baton Rouge writer covering Tesla, Elon Musk, EVs, and clean energy & supports Tesla's mission. Johnna also interviewed Elon Musk and you can listen here

Advertisement
Comments

Elon Musk

Tesla confirmed HW3 can’t do Unsupervised FSD but there’s more to the story

Tesla confirmed HW3 vehicles cannot run unsupervised FSD, replacing its free upgrade promise with a discounted trade-in.

Published

on

By

tesla autopilot

Tesla has officially confirmed that early vehicles with its Autopilot Hardware 3 (HW3) will not be capable of unsupervised Full Self-Driving, while extending a path forward for legacy owners through a discounted trade-in program. The announcement came by way of Elon Musk in today’s Tesla Q1 2026 earnings call.

The history here matters. HW3 launched in April 2019, and Tesla sold Full Self-Driving packages to owners on the understanding that the hardware was sufficient for full autonomy. Some owners paid between $8,000 and $15,000 for FSD during that period. For years, as FSD’s AI models grew more demanding, HW3 vehicles fell progressively further behind, eventually landing on FSD v12.6 in January 2025 while AI4 vehicles moved to v13 and then v14. When Musk acknowledged in January 2025 that HW3 simply could not reach unsupervised operation, and alluded to a difficult hardware retrofit.

Advertisement

The near-term offering is more concrete. Tesla’s head of Autopilot Ashok Elluswamy confirmed on today’s call that a V14-lite will be coming to HW3 vehicles in late June, bringing all the V14 features currently running on AI4 hardware. That is a meaningful software update for owners who have been frozen at v12.6 for over a year, and it represents genuine effort to keep older hardware relevant. Unsupervised FSD for vehicles is now targeted for Q4 2026 at the earliest, with Musk describing it as a gradual, geography-limited rollout.

For HW3 owners, the over-the-air V14-lite update is welcomed, and the discounted trade-in path at least acknowledges an old obligation. What happens next with the trade-in pricing will define how this chapter ultimately gets written. If Tesla prices the hardware path fairly, acknowledges what early adopters are owed, and delivers V14-lite on the June timeline it committed to today, it has a real opportunity to convert one of the longest-running sore subjects among early adopters into a loyalty story.

Continue Reading

Elon Musk

Tesla isn’t joking about building Optimus at an industrial scale: Here we go

Tesla’s Optimus factory in Texas targets 10 million robots yearly, with 5.2 million square feet under construction.

Published

on

By

Tesla’s Q1 2026 Update Letter, released today, confirms that first generation Optimus production lines are now well underway at its Fremont, California factory, with a pilot line targeting one million robots per year to start. Of bigger note is a shared aerial image of a large piece of land adjacent to Gigafactory Texas, that Tesla has prominently labeled “Optimus factory site preparation.”

Permit documents show Tesla is seeking to add over 5.2 million square feet of new building space to the Giga Texas North Campus by the end of 2026, at an estimated construction investment of $5 billion to $10 billion. The longer term production target for that facility is 10 million Optimus units per year. Giga Texas already sits on 2,500 acres with over 10 million square feet of existing factory floor, and the North Campus expansion is being built to support multiple projects, including the dedicated Optimus factory, the Terafab chip fabrication facility (a joint Tesla/SpaceX/xAI venture), a Cybercab test track, road infrastructure, and supporting facilities.

Credit: TESLA

Texas makes strategic sense beyond the existing infrastructure. The state’s tax structure, lower labor costs relative to California, and the proximity to Tesla’s AI training cluster Cortex 1 and 2, both located at Giga Texas and now totaling over 230,000 H100 equivalent GPUs, means the Optimus software stack and the factory producing the hardware will share the same campus. Tesla’s Q1 report also confirmed completion of the AI5 chip tape out in April, the inference processor designed specifically to power Optimus units in the field.

As Teslarati reported, the Texas facility is intended to house Optimus V4 production at full scale. Musk told the World Economic Forum in January that Tesla plans to sell Optimus to the public by end of 2027 at a price between $20,000 and $30,000, stating, “I think everyone on earth is going to have one and want one.” He has previously pegged long term demand for general purpose humanoid robots at over 20 billion units globally, citing both consumer and industrial use cases.

Advertisement
Continue Reading

Investor's Corner

Tesla (TSLA) Q1 2026 earnings results: beat on EPS and revenues

Published

on

Credit: Tesla

Tesla (NASDAQ: TSLA) reported its earnings for the first quarter of 2026 on Wednesday afternoon. Here’s what the company reported compared to what Wall Street analysts expected.

The earnings results come after Tesla reported a miss on vehicle deliveries for the first quarter, delivering 358,023 vehicles and building 408,386 cars during the three-month span.

As Tesla transitions more toward AI and sees itself as less of a car company, expectations for deliveries will begin to become less of a central point in the consensus of how the quarter is perceived.

Nevertheless, Tesla is leaning on its strong foundation as a car company to carry forward its AI ambitions. The first quarter is a good ground layer for the rest of the year.

Advertisement

Tesla Q1 2026 Earnings Results

Tesla’s Earnings Results are as follows:

  • Non-GAAP EPS – $0.41 Reported vs. $0.36 Expected
  • Revenues – $22.387 billion vs. $22.35 billion Expected
  • Free Cash Flow – $1.444 billion
  • Profit – $4.72 billion

Tesla beat analyst expectations, so it will be interesting to see how the stock responds. IN the past, we’ve seen Tesla beat analyst expectations considerably, followed by a sharp drop in stock price.

On the same token, we’ve seen Tesla miss and the stock price go up the following trading session.

Tesla will hold its Q1 2026 Earnings Call in about 90 minutes at 5:30 p.m. on the East Coast. Remarks will be made by CEO Elon Musk and other executives, who will shed some light on the investor questions that we covered earlier this week.

You can stream it below. Additionally, we will be doing our Live Blog on X and Facebook.

Advertisement

Continue Reading